Tyler Shultz is a researcher, founder, and whistleblower recognized for his role in exposing fraudulent practices at Theranos and advocating for ethics in innovation. After becoming a crucial confidential source for The Wall Street Journal’s investigative reporting, leading to the comprehensive exposure of fraudulent practices at Theranos, Tyler Shultz established himself as a prominent advocate for ethics in innovation. Shultz, who earned his degree in Biology from Stanford University in 2013, joined Theranos as a research engineer the same year. Initially drawn to the company’s ambitious mission to revolutionize healthcare through minimal blood samples using its proprietary Edison device, he spent over eight months diligently identifying significant issues within the organization.
Through his leadership at Flux Biosciences and The Healthyr Company, and his advisory role, he actively advocates for transparent and ethical practices across the industry while driving meaningful innovation in health diagnostics.